2.320EUR-7.20%Mkt Cap: 40.55M $P/E: 38.671d ago
ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and intern…
Industry Peers
Health Information ServicesIndicators:|
Key Statistics
Company
Market Cap40.55M $
Enterprise Value41.54M $
Revenue (TTM)8.66M $
Gross Profit7.20M $
Net Income (TTM)1.07M $
Revenue/Share0.5261 USD
Last Price2.320 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees22
CountryFR
SectorHealthcare
IndustryHealth Information Services
ISINFR001400AHX6
Valuation
P/E (Trailing)38.67
P/E (Forward)—
PEG1.94
EV/EBITDA89.22
EV/Revenue4.80
P/S4.68
P/B4.88
EPS (TTM)0.06
EPS (Forward)—
52W Range
2.1206% of range5.750
52W High5.750 EUR
52W Low2.120 EUR
Profitability
Gross Margin95.29%
Oper. Margin8.18%
EBITDA Margin5.38%
Profit Margin14.20%
ROE12.93%
ROA7.62%
Growth
Revenue Growth58.80%
Earnings Growth300.70%
Cash Flow & Leverage
Operating CF1.64M $
CapEx (TTM)861.60K $
FCF Margin13.27%
FCF Yield2.83%
Net Debt1.01M $
Net Debt/EBITDA2.18
Balance Sheet
Debt/Equity0.29
Current Ratio2.41
Quick Ratio2.08
Book Value/Sh0.4750 EUR
Cash/Share0.0820 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.1100 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split8:1
Split DateMay 18, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.16.08M
Float76.97K
Insiders97.25%
Institutions0.00%
Technical
SMA 502.874 (-19.3%)
SMA 2003.226 (-28.1%)
Beta-0.53
S&P 52W Chg20.25%
Avg Vol (30d)12.01K
Avg Vol (10d)10.21K
Technical Indicators
RSI (14)36.5
MACD-0.0941
MACD Signal-0.0884
MACD Hist.-0.0057
BB Upper2.797 EUR
BB Middle2.564 EUR
BB Lower2.331 EUR
BB Width18.18%
ATR (14)0.1862 EUR
Vol Ratio (20d)0.41x